UBS Group
NITE

UBS Group’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

UBS Group’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-43,901
Closed -$1.11M – 8444
2019
Q1 		$1.11M Buy
43,901
+42,313
+2,665% +$748K ﹤0.01% 3494
2018
Q4 		$18K Sell
1,588
-1,329
-46% -$17.7K ﹤0.01% 6893
2018
Q3 		$59K Sell
2,917
-3,428
-54% -$70.4K ﹤0.01% 6051
2018
Q2 		$102K Buy
6,345
+6,161
+3,348% +$87.9K ﹤0.01% 5432
2018
Q1 		$3K Sell
184
-876
-83% -$12K ﹤0.01% 7483
2017
Q4 		$14K Sell
1,060
-1,445
-58% -$26K ﹤0.01% 6837
2017
Q3 		$48K Buy
+2,505
New +$54.1K ﹤0.01% 5830

UBS Group's NITE Position: Q2 2019 in Review

UBS Group sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 43,901 shares — an estimated $1.11M sold.

UBS Group first reported a position in NITE in Q3 2017 and held it in 7 quarters. The position peaked at $1.11M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

  • UBS Group reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • UBS Group sold 43,901 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $1.11M.
  • UBS Group first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 7 quarters.
  • UBS Group's Nightstar Therapeutics plc American Depositary Shares position peaked at $1.11M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.